Start Codon invites life sciences leaders, founders, and investors to Innovation Showcase 2023

FHS
October 2, 2023
10:44 am

Start Codon is pleased to invite life sciences people from across the life science and biotech industries to attend their Innovation Showcase 2023.

Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder | Psychedelic Invest

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation

March 13, 2024

New Doc, Who Dis? Swift and Kelce Talk Enzymes; Worst Medical Acronym

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. New doctor, who dis? Physical medicine physician Sean Dreyer, MD,

February 2, 2024

Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.